MedPath
NMPA Approval

Ranitidine Hydrochloride Tablets

国药准字H20045137

May 19, 2020

Drug Information

盐酸雷尼替丁片

片剂

0.15g(按C13H22N4O3S计)

化学药品

May 19, 2020

Company Information

Applicant Company

Manufacturing Company

湖北省荆门市杨湾路122号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸雷尼替丁片 - NMPA 批准文号 | MedPath